{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:42:16Z","timestamp":1773373336386,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.09.044","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T18:56:35Z","timestamp":1537988195000},"page":"6703-6710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides\u2019 immunogenicity and in vitro seroneutralisation capability"],"prefix":"10.1016","volume":"36","author":[{"given":"Catalina","family":"Avenda\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"M\u00e9ndez-Callejas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo","family":"Oviedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel A.","family":"Patarroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caridad","family":"S\u00e1nchez-Acedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Qu\u00edlez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.044_b0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/pim.12350","article-title":"Cryptosporidium in humans and animals - a one health approach to prophylaxis","volume":"38","author":"Ryan","year":"2016","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2017.10.023","article-title":"Genomics and molecular epidemiology of Cryptosporidium species","volume":"184","author":"Khan","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2018.09.044_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13567-017-0447-0","article-title":"Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies","volume":"48","author":"Thomson","year":"2017","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2018.09.044_b0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/pathogens7010002","article-title":"Lessons learned from protective immune responses to optimize vaccines against cryptosporidiosis","volume":"7","author":"Lemieux","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2018.09.044_b0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.4.16-00825","article-title":"Review of Cryptosporidium and Giardia in the eastern part of Europe, 2016","volume":"23","author":"Plutzer","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.09.044_b0030","doi-asserted-by":"crossref","DOI":"10.4102\/ojvr.v83i1.1024","article-title":"Cryptosporidium genotypes in children and calves living at the wildlife or livestock interface of the Kruger National Park, South Africa","volume":"83","author":"Abu Samra","year":"2016","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2018.09.044_b0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijppaw.2015.12.001","article-title":"Public health significance of zoonotic Cryptosporidium species in wildlife: Critical insights into better drinking water management","volume":"5","author":"Zahedi","year":"2016","journal-title":"Int J Parasitol Parasites Wildl"},{"key":"10.1016\/j.vaccine.2018.09.044_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetpar.2004.09.004","article-title":"A water-borne zoonotic parasite","volume":"126","author":"Cryptosporidium","year":"2004","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.044_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pt.2006.02.015","article-title":"Giardia and Cryptosporidium join the \u201cNeglected Diseases Initiative\u201d","volume":"22","author":"Savioli","year":"2006","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.09.044_b0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/503189a","article-title":"Time to tackle cryptosporidiosis","volume":"503","author":"Striepen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.09.044_b0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biotechadv.2006.08.003","article-title":"Molecular targets for detection and immunotherapy in Cryptosporidium parvum","volume":"25","author":"Boulter-Bitzer","year":"2007","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2018.09.044_b0070","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/IAI.60.6.2343-2348.1992","article-title":"Identification and initial characterization of five Cryptosporidium parvum sporozoite antigen genes","volume":"60","author":"Petersen","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.09.044_b0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-3024.1999.00247.x","article-title":"Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses","volume":"21","author":"Sagodira","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0080","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0264-410X(99)00041-9","article-title":"Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA","volume":"17","author":"Sagodira","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.044_b0085","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/IAI.59.3.1002-1007.1991","article-title":"Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum","volume":"59","author":"Tilley","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.09.044_b0090","unstructured":"Zhou X, Tzipori S, Neutra M. Monoclonal IgA antibodies protect mice against intestinal Cryptosporidium parvum infection. Eight Int. Congr. Mucosal Immunol., San Diego, CA, USA; 1996, p. S126, 737."},{"key":"10.1016\/j.vaccine.2018.09.044_b0095","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.vaccine.2012.12.007","article-title":"Intranasal vaccination in mice with an attenuated Salmonella enterica serovar 908htr A expressing Cp15 of Cryptosporidium: Impact of malnutrition with preservation of cytokine secretion","volume":"31","author":"Roche","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.044_b0100","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/CVI.05197-11","article-title":"Identification and immunological characterization of three potential vaccinogens against Cryptosporidium species","volume":"18","author":"Manque","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0105","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.158.4.1787","article-title":"Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites","volume":"158","author":"Riggs","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0110","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/IAI.67.10.5282-5291.1999","article-title":"Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells","volume":"67","author":"Langer","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.09.044_b0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.addr.2003.10.034","article-title":"Host intestinal epithelial response to Cryptosporidium parvum","volume":"56","author":"Deng","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2018.09.044_b0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.vaccine.2018.09.044_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.2015.1075505","article-title":"Recent advances in the development of a chemically synthesised anti-malarial vaccine","volume":"15","author":"Curtidor","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2018.09.044_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.03.001","article-title":"Peptide immunotherapy in vaccine development: from epitope to adjuvant","volume":"99","author":"Yang","year":"2015","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1656(99)00107-8","article-title":"Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines","volume":"73","author":"Liljeqvist","year":"1999","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2018.09.044_b0145","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.164.5.1779","article-title":"T cell clones specific for an amphipathic alpha-helical region of sperm whale myoglobin show differing fine specificities for synthetic peptides. A multiview\/single structure interpretation of immunodominance","volume":"164","author":"Cease","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.09.044_b0150","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0168-8278(97)80090-6","article-title":"Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection","volume":"27","author":"Herv\u00e1s-Stubbs","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0166-6851(95)00050-B","article-title":"Cloning and expression of cDNA encoding an antigenic Cryptosporidium parvum protein","volume":"71","author":"Jenkins","year":"1995","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0160","first-page":"15","article-title":"Cloning and sequence analysis of the Cryptosporidium parvum CP15 Gene","author":"Mi","year":"2007","journal-title":"Chin J Anim Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.044_b0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.1094786","article-title":"Complete genome sequence of the apicomplexan, Cryptosporidium parvum","volume":"304","author":"Abrahamsen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.09.044_b0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0175","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/molecules22122199","article-title":"Conserved binding regions provide the clue for peptide-based vaccine development: a chemical perspective","volume":"22","author":"Curtidor","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2018.09.044_b0180","article-title":"Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.09.044_b0185","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1073\/pnas.82.15.5131","article-title":"General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids","volume":"82","author":"Houghten","year":"1985","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2018.09.044_b0190","first-page":"10","article-title":"Peptide synthesis: chemical or enzymatic","author":"Guzm\u00e1n","year":"2007","journal-title":"Electron J Biotechnol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0195","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis. I. The synthesis of","volume":"85","author":"Merrifield","year":"1963","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2018.09.044_b0200","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2018.09.044_b0205","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1073\/pnas.182199699","article-title":"Mechanism by which 2,2,2-trifluoroethanol\/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study","volume":"99","author":"Roccatano","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.09.044_b0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2761.2012.01354.x","article-title":"Development of a new antibody for detecting natural killer enhancing factor (NKEF)-like protein in infected salmonids","volume":"35","author":"Bethke","year":"2012","journal-title":"J Fish Dis"},{"key":"10.1016\/j.vaccine.2018.09.044_b0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-4017(93)90171-I","article-title":"Detection of oocysts and IgG antibodies to Cryptosporidium parvum in asymptomatic adult cattle","volume":"47","author":"Lorenzo Lorenzo","year":"1993","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0220","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00436-015-4390-6","article-title":"Changes in the levels of Cryspovirus during in vitro development of Cryptosporidium parvum","volume":"114","author":"Jenkins","year":"2015","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.09.044_b0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-7012(00)00198-6","article-title":"Estimating viability of Cryptosporidium parvum oocysts using reverse transcriptase-polymerase chain reaction (RT-PCR) directed at mRNA encoding amyloglucosidase","volume":"43","author":"Jenkins","year":"2000","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2018.09.044_b0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-7012(96)00970-0","article-title":"A semi-quantitative method for measuring Cryptosporidium parvum infection using polymerase chain reaction","volume":"28","author":"Jenkins","year":"1997","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2018.09.044_b0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2307\/3284557","article-title":"Development and application of an improved semiquantitative technique for detecting low-level Cryptosporidium parvum infections in mouse tissue using polymerase chain reaction","volume":"84","author":"Jenkins","year":"1998","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0240","article-title":"Advancing Cryptosporidium parvum Detection Methodologies","author":"Jenkins","year":"2002","journal-title":"Awwa Research Foundation and American Water Works Association"},{"key":"10.1016\/j.vaccine.2018.09.044_b0245","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/S0264-410X(98)00369-7","article-title":"Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice","volume":"17","author":"Jenkins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.044_b0250","series-title":"Molecular cloning: A laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.vaccine.2018.09.044_b0255","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.4161\/hv.28485","article-title":"Prospects for immunotherapy and vaccines against Cryptosporidium","volume":"10","author":"Mead","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2018.09.044_b0260","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S1567-5769(03)00016-X","article-title":"Old and new vaccine approaches","volume":"3","author":"Arnon","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0265","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4269\/ajtmh.1999.61.707","article-title":"Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil","volume":"61","author":"Guerrant","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.09.044_b0270","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1582-4934.2008.00174.x","article-title":"Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines","volume":"12","author":"Patarroyo","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.vaccine.2018.09.044_b0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.21775\/cimb.022.065","article-title":"Far from the madding crowd: The molecular basis for immunological escape of Plasmodium falciparum","volume":"22","author":"Patarroyo","year":"2017","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0280","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-3024.2009.01191.x","article-title":"Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection","volume":"32","author":"Liu","year":"2010","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/expr.2000.4545","article-title":"A 23-kDa recombinant antigen of Cryptosporidium parvum induces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice","volume":"96","author":"Bonafonte","year":"2000","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0290","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/CVI.00089-09","article-title":"Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice","volume":"16","author":"Benitez","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.044_b0295","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/349049","article-title":"Peptide-based immunotherapeutics and vaccines 2015","volume":"2015","author":"Reche","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2018.09.044_b0300","series-title":"Ley 84 de 1989","author":"Congreso Nacional de Colombia","year":"1989"},{"key":"10.1016\/j.vaccine.2018.09.044_b0305","unstructured":"Ministerio de Salud de Colombia. Resoluci\u00f3n N\u00famero 8430 de 1993. Colombia; 1993."},{"key":"10.1016\/j.vaccine.2018.09.044_b0310","unstructured":"National Research Council of the National Academies. Guide for the care and use of laboratory animals. Eighth Edi. 2011."},{"key":"10.1016\/j.vaccine.2018.09.044_b0315","unstructured":"Panel on Euthanasia. American veterinary medical association. AVMA guidelines on Euthanasia; 2007."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T12:08:04Z","timestamp":1693915684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18313136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":63,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18313136"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides\u2019 immunogenicity and in vitro seroneutralisation capability","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}